Evaxion A Asset Turnover Ratio (EVAX), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Evaxion A  (NASDAQ: EVAX)
 

Evaxion A Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Evaxion A asset turnover ratio, the ability of Evaxion A's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.28 in the fourth quarter (Dec 31 2025), a new company high.

Within sector 39 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 0 to 2981.

Asset Turnover Ratio Definition



EVAX Asset Turnover Ratio (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Asset Change 102.55 % 127.54 % 42.94 % 127.54 % -18.61 %
Y / Y Revenue Change 125.12 % - -75.97 % - 4480.82 %
Asset Turnover Ratio (TTM) 0.28 - 0.17 - 0.26
EVAX's Total Ranking # 2981 # 0 # # #
Seq. Asset Change 0 % 26.54 % -20.98 % 102.55 % 12.33 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 40
Healthcare Sector # 435
Overall Market # 2981

Asset Turnover Ratio Statistics
High Average Low
0.28 0.14 0
(Dec 31 2025)   0







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Mdxhealth Sa  0.73 $ 107.875  Millions$ 147.953  Millions
Tenet Healthcare Corp  0.73 $ 21,310.000  Millions$ 29,257.750  Millions
Novo Nordisk A  0.72 $ 309,064.000  Millions$ 428,503.574  Millions
Journey Medical Corp  0.72 $ 61.858  Millions$ 86.475  Millions
Tg Therapeutics Inc   0.72 $ 616.287  Millions$ 861.895  Millions
Lantheus Holdings Inc   0.71 $ 1,540.952  Millions$ 2,168.775  Millions
Capsovision Inc   0.71 $ 12.426  Millions$ 17.544  Millions
Heartflow Inc   0.70 $ 174.528  Millions$ 250.479  Millions
Neurocrine Biosciences Inc   0.69 $ 2,860.500  Millions$ 4,118.675  Millions
Stereotaxis Inc   0.69 $ 32.071  Millions$ 46.179  Millions
Illumina Inc   0.69 $ 4,343.000  Millions$ 6,272.500  Millions
Telix Pharmaceuticals Ltd  0.69 $ 803.438  Millions$ 1,163.986  Millions
Quest Diagnostics Inc  0.69 $ 11,035.000  Millions$ 16,047.000  Millions
Mirum Pharmaceuticals Inc   0.69 $ 521.312  Millions$ 760.999  Millions
Biomerica Inc   0.68 $ 4.458  Millions$ 6.530  Millions
Inotiv Inc   0.68 $ 514.027  Millions$ 757.788  Millions
Akebia Therapeutics Inc   0.68 $ 236.196  Millions$ 349.124  Millions
Strata Critical Medical Inc   0.67 $ 197.126  Millions$ 292.255  Millions
Phathom Pharmaceuticals Inc   0.67 $ 175.110  Millions$ 260.967  Millions
Dexcom Inc   0.67 $ 4,661.900  Millions$ 6,979.650  Millions
Resmed Inc   0.67 $ 5,365.020  Millions$ 8,055.989  Millions
Protalix Biotherapeutics inc   0.67 $ 52.744  Millions$ 79.247  Millions
Ss Innovations International Inc  0.66 $ 47.158  Millions$ 70.940  Millions
Lifestance Health Group Inc   0.66 $ 1,424.285  Millions$ 2,151.095  Millions
Mannkind Corporation  0.66 $ 348.966  Millions$ 527.165  Millions
Koninklijke Philips Nv  0.66 $ 19,974.080  Millions$ 30,177.280  Millions
Guardant Health Inc   0.66 $ 982.021  Millions$ 1,491.668  Millions
Waters Corporation  0.66 $ 3,165.286  Millions$ 4,812.191  Millions
Burning Rock Biotech Limited  0.66 $ 77.157  Millions$ 117.312  Millions
U S Physical Therapy Inc  0.66 $ 780.990  Millions$ 1,189.892  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.